ExploreWatchlistsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Diluted EPS

JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥63.8B
P/E ratio
27.5x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 202443.9+45.33%
Mar 31, 202330.2-74.13%
Mar 31, 2022116.8+110.34%
Mar 31, 202155.5-35.70%
Mar 31, 202086.4-28.01%
Mar 31, 2019120+22.27%
Mar 31, 201898.1+67.39%
Mar 31, 201758.6+5.02%
Mar 31, 201655.8+6.24%
Mar 31, 201552.5+29.64%
Mar 31, 201440.5+76.79%
Mar 31, 201322.9+16.40%
Mar 31, 201219.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat